跳至主要内容
临床试验/JPRN-jRCTs052230160
JPRN-jRCTs052230160招募中Unknown

A Single-Center Prospective Randomized Clinical Trial Comparing the Cooling Effect of Different Balloon Sizes of Cryoballoon Ablation in Patients with Paroxysmal Atrial Fibrillation - FIT study

Miyamoto Koji0 个研究点目标入组 240 人开始时间: 2024年1月9日最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
发起方
入组人数
240

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 85age old(—)
性别
All

入选标准

  • 1. Patients aged 20-85 years old
  • 2. Patients diagnosed with symptomatic paroxysmal atrial fibrillation and determined by the attending physician to require catheter ablation
  • 3. Patients with written informed consent

排除标准

  • 1. Patients with history of catheter ablation and/or surgery of atrial fibrillation
  • 2. Patients with left atrial dimension more than 55 mm
  • 3. Pregnant or potentially pregnant patients
  • 4. Patients with concomittant participation in intervention study with other medication and/or medical instrument
  • 5. Patients with active systemic infection
  • 6. Patients with atrial myxoma and/or thrombus in the heart
  • 7. Patients with artificial heart valves (mechanical or bioprosthetic valves) or a MitraClip device implanted at the site where the catheter passes
  • 8. Patients who have undergone ventricular or atrial surgery within the last 4 weeks before obtaining consent
  • 9. Patients with pulmonary vein stents in place.
  • 10. Patients with cryoglobulinemia
  • 11. Patients determined that the insertion into the atrium or operations within the atrium cannot be safely performed
  • 12. Patients with intra-atrial baffles, atrial septal defect patches, and/or other surgical interventions in the atrium or its vicinity
  • 13. Patients with severe coagulation disorders or those who cannot tolerate anticoagulation therapy during electrophysiological procedures.
  • 14. Patients for whom catheter manipulation within the cardiac chambers is considered unsafe, making invasive electrophysiological procedures contraindicated
  • 15. Patients with inaccessible vascular access or occluded femoral veins
  • 16. Severe renal impairment (estimated glomerular filtration rate <15 mL/min/1.73m2)
  • 17. Patients who cannot undergo MRI
  • 18. Patients for whom the principal investigator or co-investigator has determined that participation in the study is not appropriate.

研究者

发起方
Miyamoto Koji

相似试验